Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer
Authors
Keywords
CPT1A, Gastric cancer, Fatty acid oxidation, Prognostic, Progression
Journal
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 696, Issue -, Pages 108664
Publisher
Elsevier BV
Online
2020-11-04
DOI
10.1016/j.abb.2020.108664
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression
- (2020) Zai Luo et al. Molecular Cancer
- Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment
- (2020) Shiva Kant et al. Cell Death & Disease
- Context specificity of the EMT transcriptional response
- (2020) David P. Cook et al. Nature Communications
- PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation
- (2019) Qianqian Du et al. CANCER SCIENCE
- Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis
- (2019) Nan Li et al. Cancer Research and Treatment
- IL-17A-stimulated endothelial fatty acid β-oxidation promotes tumor angiogenesis
- (2019) Ruirui Wang et al. LIFE SCIENCES
- Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy
- (2019) Sibo Tian et al. CANCER
- UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signaling
- (2019) Jian-Xian Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling
- (2018) Yiquan Xiong et al. BIOMEDICINE & PHARMACOTHERAPY
- Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation
- (2018) Brenda Raud et al. Cell Metabolism
- Upregulation of Tiam1 contributes to cervical cancer disease progression and indicates poor survival outcome
- (2018) Yang Yang et al. HUMAN PATHOLOGY
- CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis
- (2018) Ying-nan Wang et al. ONCOGENE
- Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer
- (2018) Myoung-Hee Kang et al. Nature Communications
- Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS
- (2018) Wei Zhuo et al. GASTROENTEROLOGY
- CPT1A-mediated succinylation of S100A10 increases human gastric cancer invasion
- (2018) Chao Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α
- (2018) An Xu et al. CANCER LETTERS
- IRTKS is correlated with progression and survival time of patients with gastric cancer
- (2017) Li-Yu Huang et al. GUT
- Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
- (2017) Thomas W. Flaig et al. Oncotarget
- The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
- (2016) Sander M. Houten et al. Annual Review of Physiology
- Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
- (2016) Q Qu et al. Cell Death & Disease
- Lipid metabolic reprogramming in cancer cells
- (2016) S Beloribi-Djefaflia et al. Oncogenesis
- High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia
- (2016) Jinlong Shi et al. EBioMedicine
- Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias
- (2015) M. R. Ricciardi et al. BLOOD
- Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer
- (2015) Huanjie Shao et al. Oncotarget
- Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
- (2014) I. R. Schlaepfer et al. MOLECULAR CANCER THERAPEUTICS
- An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer
- (2014) Michael L Gatza et al. NATURE GENETICS
- Pre-B-cell leukemia homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and migration
- (2014) Dannis G. van Vuurden et al. NEURO-ONCOLOGY
- Quantitative Proteomics Analysis Identifies Mitochondria as Therapeutic Targets of Multidrug-Resistance in Ovarian Cancer
- (2014) Xiulan Chen et al. Theranostics
- Metabolomics reveals that carnitine palmitoyltransferase-1 is a novel target for oxidative inactivation in human cells
- (2013) Daiki Setoyama et al. GENES TO CELLS
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation
- (2010) Sander Michel Houten et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Regulatory enzymes of mitochondrial β-oxidation as targets for treatment of the metabolic syndrome
- (2009) M. Schreurs et al. Obesity Reviews
- Carnitine palmitoyltransferase 1: Central to cell function
- (2008) Victor A. Zammit IUBMB LIFE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started